Pascal and Francis Bibliographic Databases

Help

Search results

Your search

is.\*:("1359-6349")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 640

  • Page / 26
Export

Selection :

  • and

Exploring potential treatment options for patients with recurrent ovarian cancer unsuited to receive platinum: a focus on trabectedinGABRA, Hani.European journal of cancer. Supplement (1990). 2014, Vol 12, Num 2, issn 1359-6349, 22 p.Serial Issue

The EORTC Breast Cancer Group: major achievements of 50 years of research and future directionsCUFER, Tanja; CARDOSO, Fatima; VAN'T VEER, Laura et al.European journal of cancer. Supplement (1990). 2012, Vol 10, Num 1, pp 27-33, issn 1359-6349, 7 p.Article

Achievements of the EORTC Soft Tissue and Bone Sarcoma GroupHOHENBERGER, Peter; VAN GLABBEKE, Martine; OUALI, Monia et al.European journal of cancer. Supplement (1990). 2012, Vol 10, Num 1, pp 160-166, issn 1359-6349, 7 p.Article

Calculating yttrium-90 activity with clinical considerationsKENNEDY, Andrew S.European journal of cancer. Supplement (1990). 2012, Vol 10, Num 3, pp 59-61, issn 1359-6349, 3 p.Conference Paper

Liver resection post-selective internal radiation therapy ― an overviewBERRY, David P.European journal of cancer. Supplement (1990). 2012, Vol 10, Num 3, pp 36-38, issn 1359-6349, 3 p.Conference Paper

Late Breaking, Best of and Award Abstracts 2011 European Multidisciplinary Cancer Congress (ECCO16, ESMO36, ESTRO30): integrating basic & translational science, surgery, radiotherapy, medical oncology, advocacy & care, Stockholm, 23-27 September 2011European journal of cancer. Supplement (1990). 2011, Vol 47, Num 2, issn 1359-6349, 18 p.Conference Proceedings

Case histories: breast cancerGENNARI, Alessandra; PIETRI, Elisabetta; AMADORI, Dino et al.European journal of cancer. Supplement (1990). 2011, Vol 9, Num 2, pp 36-42, issn 1359-6349, 7 p.Article

The role of nab™-paclitaxel in managing metastatic breast cancer: a report of three casesDAVIDSON, Neville.European journal of cancer. Supplement (1990). 2010, Vol 8, Num 1, pp 11-18, issn 1359-6349, 8 p.Article

Abstracts of the EORTC-NCI-ASCO Annual Meeting on 'Molecular Markers in Cancer'European journal of cancer. Supplement (1990). 2009, Vol 7, Num 4, issn 1359-6349, 57 p.Conference Proceedings

Cancer Prevention 2008European journal of cancer. Supplement (1990). 2008, Vol 6, Num 3, issn 1359-6349, 64 p.Conference Proceedings

Proceedings of the Rome Forum on the Treatment of Breast CancerEuropean journal of cancer. Supplement (1990). 2008, Vol 6, Num 8, issn 1359-6349, 20 p.Conference Proceedings

Management of HER-2/neu-positive metastatic breast cancerAWADA, Ahmad; PICCART-GEBHART, Martine J.European journal of cancer. Supplement (1990). 2008, Vol 6, Num 4, pp 2-9, issn 1359-6349, 8 p.Article

VEGF and angiogenesis : implications for breast cancer therapyDREUS, Joachim.European journal of cancer. Supplement (1990). 2008, Vol 6, Num 6, pp 7-13, issn 1359-6349, 7 p.Article

Future use of bevacizumab and other anti-angiogenic agents in breast cancerCAMERON, David; BELL, Richard.European journal of cancer. Supplement (1990). 2008, Vol 6, Num 6, pp 40-50, issn 1359-6349, 11 p.Article

Integrative Molecular Cancer Epidemiology — An IARC-EACR-AACR-ECNIS SymposiumEuropean journal of cancer. Supplement (1990). 2008, Vol 6, Num 9, pp 181-211, issn 1359-6349, 30 p.Conference Paper

Circulating tumour cells in colorectal cancerDI COSTANZO, Francesco; PINZANI, Pamela; ORLANDO, Claudio et al.European journal of cancer. Supplement (1990). 2008, Vol 6, Num 14, pp 52-59, issn 1359-6349, 8 p.Conference Paper

Clinical results of EGFR-targeted therapies in advanced colorectal cancerMAIELLO, Evaristo; GEBBIA, Vittorio; MANZIONE, Luigi et al.European journal of cancer. Supplement (1990). 2008, Vol 6, Num 14, pp 64-69, issn 1359-6349, 6 p.Conference Paper

Molecular and preclinical models enhancing anti-tumour activity of zoledronic acidMARRA, M; SANTINI, D; CARAGLIA, M et al.European journal of cancer. Supplement (1990). 2008, Vol 6, Num 14, pp 79-85, issn 1359-6349, 7 p.Conference Paper

Molecular predictive factors of response to anti-EGFR antibodies in colorectal cancer patientsSANTINI, Daniele; PANTANO, Francesco; VINCENZI, Bruno et al.European journal of cancer. Supplement (1990). 2008, Vol 6, Num 14, pp 86-90, issn 1359-6349, 5 p.Conference Paper

Review of gemcitabine plus taxane combination therapy in the first-line treatment of metastatic breast cancerCOLOMER, Ramon.European journal of cancer. Supplement (1990). 2008, Vol 6, Num 8, pp 9-12, issn 1359-6349, 4 p.Conference Paper

Optimising therapeutic options for women's cancersO'SHAUGHNESSY, Joyce; VERGOTE, Ignace.European journal of cancer. Supplement (1990). 2007, Vol 5, Num 1, issn 1359-6349, 45 p.Serial Issue

Targeted therapy in metastatic renal cell carcinoma: efficacy, adverse-event management and key considerationsRAVAUD, Alain.European journal of cancer. Supplement (1990). 2007, Vol 5, Num 7, issn 1359-6349, 36 p.Serial Issue

Case Report 3. Sunitinib malate in patients with cerebellar metastasesNEGRIER, Syluie.European journal of cancer. Supplement (1990). 2007, Vol 5, Num 7, pp 32-34, issn 1359-6349, 3 p.Article

Biomarkers for safety and toxicology : Drug induced cardiac injury and dysfunctionDUFFY, Paul A; BETTON, Graham; ROBERTS, Ruth A et al.European journal of cancer. Supplement (1990). 2007, Vol 5, Num 5, pp 143-151, issn 1359-6349, 9 p.Conference Paper

Leptomeningeal metastasis in solid tumours : Is there a role for intrathecal therapy?BOOGERD, Willem.European journal of cancer. Supplement (1990). 2007, Vol 5, Num 5, pp 41-51, issn 1359-6349, 11 p.Conference Paper

  • Page / 26